These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 16152779
1. [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha]. D'Angelo-Mendoza E, Rodríguez-Bonfante C, Camacho I, Martínez J, Perdomo T, Cabrera A, Bonfante-Cabarcas R. Invest Clin; 2005 Sep; 46(3):229-40. PubMed ID: 16152779 [Abstract] [Full Text] [Related]
2. The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Mocelin AO, Issa VS, Bacal F, Guimarães GV, Cunha E, Bocchi EA. Eur J Heart Fail; 2005 Aug; 7(5):869-73. PubMed ID: 16043406 [Abstract] [Full Text] [Related]
4. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Rodríguez-Pérez JM, Cruz-Robles D, Hernández-Pacheco G, Pérez-Hernández N, Murguía LE, Granados J, Reyes PA, Vargas-Alarcón G. Immunol Lett; 2005 Apr 15; 98(1):97-102. PubMed ID: 15790514 [Abstract] [Full Text] [Related]
5. Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure. Mady C, Ianni BM, Arteaga E, Salemi VM, de Carvalho Frimm C. J Card Fail; 2000 Sep 15; 6(3):220-4. PubMed ID: 10997748 [Abstract] [Full Text] [Related]
6. [Left ventricular mechanics in Chagas' disease and primary dilated myocardiopathies. A hemodynamic study]. Gómez de Pereira C, Carrasco HA, Guerrero L, Parada H, Molina C, Chuecos R. Arch Inst Cardiol Mex; 1991 Sep 15; 61(5):435-40. PubMed ID: 1772315 [Abstract] [Full Text] [Related]
7. [Comparison of histologic changes in Chagas' cardiomyopathy and dilated cardiomyopathy]. Barretto AC, Higuchi ML, da Luz PL, Lopes EA, Bellotti G, Mady C, Stolf N, Arteaga-Fernández E, Pileggi F. Arq Bras Cardiol; 1989 Feb 15; 52(2):79-83. PubMed ID: 2596992 [Abstract] [Full Text] [Related]
8. [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure]. López L, Arai K, Giménez E, Jiménez M, Pascuzo C, Rodríguez-Bonfante C, Bonfante-Cabarcas R. Rev Esp Cardiol; 2006 Jan 15; 59(1):50-6. PubMed ID: 16434004 [Abstract] [Full Text] [Related]
9. [Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings]. Kalil R, Bocchi EA, Ferreira BM, de Lourdes Higuchi M, Lopes NH, Magalhães AC, Mady C, Pereira Barretto AC, Albuquerque CP, Bellotti G. Arq Bras Cardiol; 1995 Nov 15; 65(5):413-6. PubMed ID: 8729858 [Abstract] [Full Text] [Related]
10. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Hernández-Becerril N, Nava A, Reyes PA, Monteón VM. Arch Cardiol Mex; 2001 Nov 15; 71(3):199-205. PubMed ID: 11665655 [Abstract] [Full Text] [Related]
11. Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy. Laguens RP, Argel MI, Chambó J, Storino R, Cabeza Meckert PM. Can J Cardiol; 1994 Sep 15; 10(7):769-76. PubMed ID: 7922834 [Abstract] [Full Text] [Related]
12. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy. Cunha AB, Cunha DM, Pedrosa RC, Flammini F, Silva AJ, Saad EA, Kopiler DA. Rev Port Cardiol; 2003 Jan 15; 22(1):29-52. PubMed ID: 12712809 [Abstract] [Full Text] [Related]
13. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. Nunes Mdo C, Rocha MO, Ribeiro AL, Colosimo EA, Rezende RA, Carmo GA, Barbosa MM. Int J Cardiol; 2008 Jul 21; 127(3):372-9. PubMed ID: 17689706 [Abstract] [Full Text] [Related]
14. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM. Clin Infect Dis; 2004 Apr 01; 38(7):943-50. PubMed ID: 15034825 [Abstract] [Full Text] [Related]
15. [Specific dilated myocardiopathy. Chronic chagasic cardiopathy at the National Institute of Cardiology Ignacio Chávez]. Monteón-Padilla VM, Vargas-Alarcón G, Vallejo-Allende M, Reyes PA. Arch Cardiol Mex; 2002 Apr 01; 72 Suppl 1():S148-52. PubMed ID: 12001835 [Abstract] [Full Text] [Related]
16. [Behavior of the ST segment, during isometric exercise, in chagasic patients with apical aneurysm of the left ventricle]. Torres A, Donis JH, Navas M, Fuenmayor AJ, Gottberg C, Dávila DF. Arch Inst Cardiol Mex; 1989 Apr 01; 59(5):499-504. PubMed ID: 2604492 [Abstract] [Full Text] [Related]
17. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease. Maçao LB, Wilhelm Filho D, Pedrosa RC, Pereira A, Backes P, Torres MA, Fröde TS. Int J Cardiol; 2007 Dec 15; 123(1):43-9. PubMed ID: 17328977 [Abstract] [Full Text] [Related]
18. Endothelial function is preserved in Chagas' heart disease patients without heart failure. Consolim-Colombo FM, Lopes HF, Rosetto EA, Rubira MC, Barreto-Filho JA, Baruzzi AC, Rocha NN, Mady C, Irigoyen MC, Krieger EM. Endothelium; 2004 Dec 15; 11(5-6):241-6. PubMed ID: 15763943 [Abstract] [Full Text] [Related]
19. The relationship between heart rate variability and serum cytokines in chronic chagasic patients with persistent parasitemia. Llaguno M, Pertili LA, da Silva MV, Bunazar P, Reges AM, Faleiros AC, Lages-Silva E, Rodrigues Junior V, da Silva VJ, Correia Filho D. Pacing Clin Electrophysiol; 2011 Jun 15; 34(6):724-35. PubMed ID: 21276024 [Abstract] [Full Text] [Related]
20. [Relationship between ventricular arrhythmia and cardiac function in Chagas disease]. Barretto AC, Mady C, Ianni BM, Arteaga E, Cardoso RH, da Luz PL, Pileggi F. Arq Bras Cardiol; 1995 Jun 15; 64(6):533-5. PubMed ID: 8561672 [Abstract] [Full Text] [Related] Page: [Next] [New Search]